Biomedical Advanced Research and Development Authority

BARDA awards Novan $7.8 million contract

Tuesday, August 27, 2013

The U.S. Department of Health and Human Services has entered into a contract with Novan, a clinical-stage drug development company focused on topical delivery of nitric oxide, to advance the development of a nitric oxide-based therapy as a topical treatment for thermal burns. 

[Read More]